The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

Share Price Information for Blackstone Loan (BGLF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.59
Bid: 0.57
Ask: 0.61
Change: 0.00 (0.00%)
Spread: 0.04 (7.018%)
Open: 0.59
High: 0.59
Low: 0.59
Prev. Close: 0.59
BGLF Live PriceLast checked at -
Blackstone/GSO Loan Financing is an Investment Trust

To provide shareholders with stable and growing income returns, and to grow the capital value of the investment portfolio by exposure to all debt tranches of CLOs (CLO Income Notes and other CLO Securities) and in Loan Warehouses.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shareholder Consultation

26 Jan 2023 09:37

RNS Number : 9676N
Blackstone Loan Financing Limited
26 January 2023
 

26 January 2023

Blackstone Loan Financing Limited

(the "Company")

Shareholder Consultation

The Board announces a shareholder consultation on potential policy amendments in light of the prevailing and persistent discount to net asset value ("NAV") at which the Company's shares trade and with a view to broadening investor interest in the Company's shares and maximising shareholder total return. Although the Company has implemented multiple share buyback programmes to assist in managing the discount to NAV, the Board believes that greater measures are required. The Board will therefore commence a shareholder consultation to seek views on two potential policy amendments:

Potential Exit Opportunity

The Board is giving consideration to a potential exit opportunity for shareholders, either as a one-off event or over regular intervals. It is expected that should such proposal be put forward to shareholders, any exit opportunity will be by way of the creation of a new share class, which would return capital to holders of such shares as investments are realised over time.

Reinvestment/Distribution of Excess Net Income

On 23 January 2023, the Company announced its target annual dividend for 2023 of between €0.08 and €0.09 per ordinary share, which will consist of quarterly payments of €0.02 per ordinary share for the first three quarters and a final quarter payment of a variable amount to be determined at that time(1). This represents an increase over the 2022 annual target of between €0.07 and €0.08 per ordinary share, and a dividend yield of between 11.27% and 12.86% based on the BGLF closing price of €0.71 on 20 January 2023.

The target annual dividend is set at a level that the Board believes provides an attractive income to shareholders, while also allowing the Company to retain a proportion of the distributions it receives from Blackstone Corporate Funding ("BCF") (after costs) ("Excess Net Income") for share repurchases to manage the share price discount to NAV and re-investment.

The Board intends to consult with shareholders over the potential for a reallocation of the Excess Net Income to allow for either or any combination of:

· an expansion of the existing share buyback programme;

· a potential further increase in the quarterly and/or annual dividend level; or

· direct primary market CLO Income Note investments in Blackstone managed and controlled CLOs. Such investments will be similar to those indirectly owned by the Company through its investment via BCF.

Singer Capital Markets and Winterflood Securities, joint financial advisers and brokers to the Company, will contact key shareholders in due course. Any institutional shareholders not contacted by Singer Capital Markets or Winterflood Securities wishing to participate in the shareholder consultation are invited to contact Singer Capital Markets or Winterflood Securities.

The results of the Board's review following the shareholder consultation process will be announced in due course. Any proposals may be conditional on approval by shareholders at an EGM, and further details, including the benefits to the Company and its shareholders, and any potential related risks, will be set out in a shareholder circular convening the EGM to be published by the Company if appropriate.

(1) The target dividend set out in this announcement is a target only and not a profit forecast. It should not be taken as an indication of the Company's expected future performance or results. There is no guarantee that the target dividend set out in this announcement can or will be achieved or can be continued if achieved. There may be other additional risks, uncertainties and factors that could cause the returns generated by the Company to be materially lower than the target dividend set out in this announcement. Accordingly, investors should not place any reliance on such target.

 

 

The information contained within this announcement constitutes inside information.

The person responsible for arranging for the release of this announcement on behalf of the Company is Nicole Troy of BNP Paribas S.A., Jersey Branch, Company Secretary.

Enquiries:

 

Blackstone Loan Financing Limited

Charlotte Valeur, Chair

 

via BNP Paribas

BNP Paribas

 

01534 709178 / 813873

Singer Capital Markets

James Maxwell / Alaina Wong (Corporate Finance)

Alan Geeves / Sam Greatrex (Sales)

 

020 7496 3000

 

Winterflood Investment Trusts

Neil Langford (Corporate Finance)

Darren Willis (Sales)

020 3100 0000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFVALEIRFIV
Date   Source Headline
22nd Apr 20247:00 amRNSDividend Declaration
22nd Apr 20247:00 amRNSNet Asset Value and Publication of Monthly Report
19th Apr 202412:31 pmRNSDirector Declaration
22nd Mar 20247:00 amRNSNet Asset Value and Publication of Monthly Report
23rd Feb 20244:44 pmRNSDIVIDEND CURRENCY ELECTION
22nd Feb 20247:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
23rd Jan 20247:00 amRNSDividend Declaration
22nd Jan 20245:05 pmRNSNet Asset Value and Publication of Monthly Report
22nd Dec 20237:00 amRNSCancellation of Treasury Shares
21st Dec 20234:13 pmRNSIssuance of Deferred Share
21st Dec 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
21st Nov 20231:17 pmRNSDIVIDEND CURRENCY ELECTION
21st Nov 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
13th Nov 20234:20 pmRNSQ3 2023 Report and Investor Call
20th Oct 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:00 amRNSDividend Declaration
26th Sep 20237:00 amRNSHalf-year Report
21st Sep 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
15th Sep 20231:21 pmRNSResult of Extraordinary General Meeting
25th Aug 20237:00 amRNSNotice of Extraordinary General Meeting
24th Aug 20234:07 pmRNSDirectorate Change
22nd Aug 20237:00 amRNSNet Asset Value and Publication of Monthly Report
9th Aug 20233:56 pmRNSQ2 2023 Report and Investor Call
26th Jul 20234:29 pmRNSBoard Update
26th Jul 20234:29 pmRNSResult of AGM
21st Jul 20237:00 amRNSDividend Declaration
21st Jul 20237:00 amRNSNet Asset Value and Publication of Monthly Report
10th Jul 20235:21 pmRNSNotice of Annual General Meeting
23rd Jun 20236:09 pmRNSProposed Managed Wind-Down of the Company
22nd Jun 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
23rd May 20237:00 amRNSNet Asset Value and Publication of Monthly Report
11th May 20236:04 pmRNSQ1 2023 Report and Investor Call
28th Apr 20237:00 amRNSAnnual Financial Report
25th Apr 20237:00 amRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
3rd Apr 20234:54 pmRNSTotal Voting Rights
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSNet Asset Value(s)
17th Mar 20237:00 amRNSResults of Shareholder Consultation
2nd Mar 20235:31 pmRNSTransaction in Own Shares
2nd Mar 20235:08 pmRNSTransaction in Own Shares
1st Mar 20235:11 pmRNSTransaction in Own Shares
1st Mar 20233:05 pmRNSTotal Voting Rights
24th Feb 20234:18 pmRNSDIVIDEND CURRENCY ELECTION
22nd Feb 20237:00 amRNSNet Asset Value and Publication of Monthly Report
10th Feb 20234:48 pmRNSTransaction in Own Shares
10th Feb 20234:12 pmRNSNon-material change to Investment Policy
10th Feb 20231:58 pmRNSQ4 2022 Report and Investor Call
1st Feb 20233:36 pmRNSHolding(s) in Company
1st Feb 20231:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.